Sign in
MTNB Stock Price, Chart, Stats & News
Matinas BioPharma Holdings, Inc.
Save
Matinas BioPharma Holdings, Inc. (MTNB) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
MTNB chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | 0.46% |
ROA | -180.34% |
ROE | -249.82% |
D/E | 0.36x |
Interest coverage ratio | – |
MTNB valuation
P/E | – |
P/S | – |
P/B | 0.47x |
P/CF | -0.34x |
P/FCF | -0.35x |
P/OCF | -0.34x |
PEG | -0.02x |
EV multiple | -0.64x |
About
Matinas BioPharma Holdings, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to identifying and advancing a range of potential therapeutic products. The company's innovative Lipid Nanocrystal (LNC) platform technology underpins its product development efforts. This sophisticated LNC delivery system leverages lipid nano-crystals to transport a diverse array of therapeutic agents, including small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides.
Similar securities
Based on sector and market capitalization
Report issue